Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Kidney Neoplasms

ng-nitroarginine methyl ester has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pertijs, J; Rongen, GA; Thijs, AM; van den Broek, PH; van der Graaf, WT; van Herpen, CM; Verweij, V1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Kidney Neoplasms

ArticleYear
Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension.
    Journal of hypertension, 2015, Volume: 33, Issue:10

    Topics: Acetylcholine; Adult; Aged; Angiogenesis Inhibitors; Animals; Carcinoma, Renal Cell; Endothelium, Vascular; Forearm; Humans; Hypertension; Indoles; Kidney Neoplasms; Male; Mesenteric Arteries; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pyrroles; Rats; Regional Blood Flow; Sunitinib; Vascular Endothelial Growth Factor A; Vasodilation; Vasodilator Agents

2015